Spa Cology Sport Sunscreen Spf 30

Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone


Fruit Of The Earth, Inc.
Human Otc Drug
NDC 62217-150
Spa Cology Sport Sunscreen Spf 30 also known as Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone is a human otc drug labeled by 'Fruit Of The Earth, Inc.'. National Drug Code (NDC) number for Spa Cology Sport Sunscreen Spf 30 is 62217-150. This drug is available in dosage form of Spray. The names of the active, medicinal ingredients in Spa Cology Sport Sunscreen Spf 30 drug includes Avobenzone - 30 mg/g Homosalate - 100 mg/g Octisalate - 50 mg/g Octocrylene - 20 mg/g Oxybenzone - 40 mg/g . The currest status of Spa Cology Sport Sunscreen Spf 30 drug is Active.

Drug Information:

Drug NDC: 62217-150
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Spa Cology Sport Sunscreen Spf 30
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Avobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Fruit Of The Earth, Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Spray
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:AVOBENZONE - 30 mg/g
HOMOSALATE - 100 mg/g
OCTISALATE - 50 mg/g
OCTOCRYLENE - 20 mg/g
OXYBENZONE - 40 mg/g
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH NOT FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 14 Nov, 2017
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 19 May, 2024
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part352
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:FRUIT OF THE EARTH, INC.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:G63QQF2NOX
V06SV4M95S
4X49Y0596W
5A68WGF6WM
95OOS7VE0Y
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
62217-150-37156 g in 1 CAN (62217-150-37)14 Nov, 2017N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose sunscreen

Product Elements:

Spa cology sport sunscreen spf 30 avobenzone, homosalate, octisalate, octocrylene, oxybenzone alcohol acrylate/isobutyl methacrylate/n-tert-octylacrylamide copolymer (75000 mw) stearoxytrimethylsilane glycerin diethylhexyl syringylidenemalonate tocopherol vitamin a palmitate medium-chain triglycerides avobenzone avobenzone homosalate homosalate octisalate octisalate octocrylene octocrylene oxybenzone oxybenzone

Indications and Usage:

Uses helps prevent sunburn if used as directed with other sun protection measures (see ?directions ?), decreases the risk of skin cancer and early skin aging caused by the sun

Warnings:

Warnings ?for external use only

Do Not Use:

Warnings ?for external use only

When Using:

When using this product keep out of eyes. rinse with water to remove. do not puncture or incinerate. contents under pressure. do not store at temperatures above 120° f.

Dosage and Administration:

Directions • apply liberally 15 minutes before sun exposure • hold can 4-6 inches away from body, spray evenly to ensure complete coverage • do not spray into face. spray into hand and apply to face. • use in well ventilated, but not windy areas • reapply: • after 80 minutes of swimming or sweating • immediately after towel drying • at least every 2 hours • children under 6 months: ask a doctor • sun protection measures . spending time in the sun increases your risk of skin cancer and early skin aging. to decrease this risk, regularly use a sunscreen with a broad-spectrum spf value of 15 or higher and other sun protection measures including: • limit time in the sun, especially from 10 a.m. - 2 p.m. • wear long-sleeved shirts, pants, hats, and sunglasses

Stop Use:

Stop use and ask doctor if? rash occurs.

Package Label Principal Display Panel:

Label sp29030d


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.